GAMMA Investing’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1K Sell
1,908
-524
-22% -$3.21K ﹤0.01% 2809
2026
Q1
$18.6K Buy
2,432
+1,938
+392% +$14.8K ﹤0.01% 2747
2025
Q4
$4.8K Sell
494
-33
-6% -$281 ﹤0.01% 3297
2025
Q3
$2.21K Sell
527
-158
-23% -$1.01K ﹤0.01% 3426
2025
Q2
$6.36K Sell
685
-217
-24% -$1.89K ﹤0.01% 3023
2025
Q1
$8.79K Buy
902
+20
+2% +$248 ﹤0.01% 2809
2024
Q4
$10.7K Buy
882
+20
+2% +$243 ﹤0.01% 2577
2024
Q3
$9.45K Buy
862
+398
+86% +$4.04K ﹤0.01% 2486
2024
Q2
$4.18K Buy
464
+211
+83% +$1.47K ﹤0.01% 2643
2024
Q1
$2.07K Buy
253
+200
+377% +$1.64K ﹤0.01% 2736
2023
Q4
$411 Buy
+53
New +$614 ﹤0.01% 3002

Other funds holding REPL

GAMMA Investing's REPL Position: Q2 2026 in Review

GAMMA Investing reduced its Replimune Group (REPL) stake by 22% in Q2 2026, selling an estimated $3.21K and leaving 1,908 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

GAMMA Investing first reported a position in REPL in Q4 2023 and has held it in 11 quarters since. 16 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • GAMMA Investing held 1,908 shares of Replimune Group worth $21.1K as of Q2 2026.
  • GAMMA Investing sold 524 Replimune Group shares in Q2 2026, an estimated $3.21K.
  • Replimune Group made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2809 holding.
  • GAMMA Investing first reported a position in Replimune Group in Q4 2023 and has held it in 11 quarters since.
  • 16 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.